BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1834109)

  • 1. Prophylaxis and empiric therapy for streptococcal infections in febrile neutropenic patients.
    Voit M; Klastersky J
    Eur J Cancer; 1991; 27(7):818-9. PubMed ID: 1834109
    [No Abstract]   [Full Text] [Related]  

  • 2. Infections of febrile neutropenic patients in malignant hematological diseases.
    Rókusz L; Liptay L
    Mil Med; 2003 May; 168(5):355-9. PubMed ID: 12775168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infections caused by viridans streptococci in patients with neutropenia.
    Tunkel AR; Sepkowitz KA
    Clin Infect Dis; 2002 Jun; 34(11):1524-9. PubMed ID: 12015700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology and risk factors for gram-positive coccal infections in neutropenia: toward a more targeted antibiotic strategy.
    Cordonnier C; Buzyn A; Leverger G; Herbrecht R; Hunault M; Leclercq R; Bastuji-Garin S;
    Clin Infect Dis; 2003 Jan; 36(2):149-58. PubMed ID: 12522746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viridans streptococcal bacteraemia in patients with neutropenia.
    Richard P; Amador Del Valle G; Moreau P; Milpied N; Felice MP; Daeschler T; Harousseau JL; Richet H
    Lancet; 1995 Jun; 345(8965):1607-9. PubMed ID: 7783538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empiric treatment of localized infections in the febrile neutropenic patient with monotherapy.
    Donnelly JP; Novakova IR; Raemaekers JM; De Pauw BE
    Leuk Lymphoma; 1993 Feb; 9(3):193-203. PubMed ID: 8471978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Empirical antifungal therapy in patients with febrile neutropenia].
    Nucci M
    Drugs Today (Barc); 2010 Apr; 46 Suppl C():13-20. PubMed ID: 20490378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefpodoxime for antimicrobial prophylaxis in neutropenia: a retrospective case series.
    Wojenski DJ; Barreto JN; Wolf RC; Tosh PK
    Clin Ther; 2014 Jun; 36(6):976-81. PubMed ID: 24832560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imipenem-cilastatin versus piperacillin-tazobactam as monotherapy in febrile neutropenia.
    Vural S; Erdem E; Gulec SG; Yildirmak Y; Kebudi R
    Pediatr Int; 2010 Apr; 52(2):262-7. PubMed ID: 19744230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral versus intravenous antibiotics in treatment of paediatric febrile neutropenia.
    Vedi A; Cohn R
    J Paediatr Child Health; 2013 Mar; 49(3):170-8. PubMed ID: 22136103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of neutropenia.
    Rolston KV
    Int J Antimicrob Agents; 2000 Oct; 16(2):113-5. PubMed ID: 11053790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Febrile neutropenia: a prospective study to validate the Multinational Association of Supportive Care of Cancer (MASCC) risk-index score.
    Uys A; Rapoport BL; Anderson R
    Support Care Cancer; 2004 Aug; 12(8):555-60. PubMed ID: 15197637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamics and pharmacokinetics of antibacterial drugs in the management of febrile neutropenia.
    Lortholary O; Lefort A; Tod M; Chomat AM; Darras-Joly C; Cordonnier C;
    Lancet Infect Dis; 2008 Oct; 8(10):612-20. PubMed ID: 18922483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial infections in low-risk, febrile neutropenic patients.
    Kamana M; Escalante C; Mullen CA; Frisbee-Hume S; Rolston KV
    Cancer; 2005 Jul; 104(2):422-6. PubMed ID: 15937905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Empirical therapy of infections in neutropenic patients.
    Gaya H
    Br J Haematol; 1998 May; 101 Suppl 1():5-9. PubMed ID: 9607734
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prophylactic antibiotic treatment of neutropenic patients].
    Telekes A; Hegedüs M
    Orv Hetil; 2004 Jul; 145(28):1451-7. PubMed ID: 15366711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of various antibiotic combinations for the empiric treatment of neutropenic febrile children.
    Anak S; Devecioğlu O; Ağaoğlu L; Zülfikar B; Ayan I; Atilgan N; Yalman N; Bilgen H; Kaya G; Gedikoğlu G
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():104. PubMed ID: 2697388
    [No Abstract]   [Full Text] [Related]  

  • 18. Experience with cefepime versus meropenem as empiric monotherapy for neutropenia and fever in pediatric patients with solid tumors.
    Oguz A; Karadeniz C; Citak EC; Cil V; Eldes N
    Pediatr Hematol Oncol; 2006; 23(3):245-53. PubMed ID: 16517540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empiric single agent or combination antibiotic therapy for febrile episodes in neutropenic patients: an overview.
    Lieschke GJ; Bell D; Rawlinson W; Green MD; Sheridan W; Morstyn G; Stuart-Harris R; Kefford RF; Levi J; Sorrell T
    Eur J Cancer Clin Oncol; 1989; 25 Suppl 2():S37-42. PubMed ID: 2693108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline.
    Flowers CR; Seidenfeld J; Bow EJ; Karten C; Gleason C; Hawley DK; Kuderer NM; Langston AA; Marr KA; Rolston KV; Ramsey SD
    J Clin Oncol; 2013 Feb; 31(6):794-810. PubMed ID: 23319691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.